PlainRecalls
FDA Drug Low Class III Terminated

PLUVICTO 1,000MBq/mL (27 mCi/mL), lutetium Lu 177 vipivotide tetraxetan injection, 9.2 mL Single-dose vial, Manufacturer: Advanced Accelerator Appllications USA, Inc., 57 E. Willow Street NJ 07041, Milburn, USA, NDC 69488-010-61

Reported: August 23, 2023 Initiated: August 7, 2023 #D-1085-2023

Product Description

PLUVICTO 1,000MBq/mL (27 mCi/mL), lutetium Lu 177 vipivotide tetraxetan injection, 9.2 mL Single-dose vial, Manufacturer: Advanced Accelerator Appllications USA, Inc., 57 E. Willow Street NJ 07041, Milburn, USA, NDC 69488-010-61

Reason for Recall

Labeling: Incorrect or Missing Lot and/or Exp Date: vials were labeled with the incorrect lot number and expiration date

Details

Units Affected
10
Distribution
Distributed Nationwide in the USA
Location
Millburn, NJ

Frequently Asked Questions

What product was recalled?
PLUVICTO 1,000MBq/mL (27 mCi/mL), lutetium Lu 177 vipivotide tetraxetan injection, 9.2 mL Single-dose vial, Manufacturer: Advanced Accelerator Appllications USA, Inc., 57 E. Willow Street NJ 07041, Milburn, USA, NDC 69488-010-61. Recalled by Advanced Accelerator Applications USA, Inc.. Units affected: 10.
Why was this product recalled?
Labeling: Incorrect or Missing Lot and/or Exp Date: vials were labeled with the incorrect lot number and expiration date
Which agency issued this recall?
This recall was issued by the FDA Drug on August 23, 2023. Severity: Low. Recall number: D-1085-2023.